ストックスクリーナーアプリを入手
76.10
1.91%
1.49
前日終値:
$74.61
開ける：
$73.86
24時間の取引高:
100.88K
Relative Volume:
0.17
時価総額：
$3.47B
収益：
$1.36B
当期純損益:
$123.81M
株価収益率:
31.58
EPS:
2.41
ネットキャッシュフロー:
$20.35M
1週間 パフォーマンス:
+4.07%
1か月 パフォーマンス:
+12.29%
6か月 パフォーマンス:
-2.62%
1年 パフォーマンス:
-8.10%
1日の値動き範囲:
$73.86
$76.42
1週間の範囲:
$72.39
$76.42
52週間の値動き範囲:
$55.30
$94.98
Haemonetics Corp Stock (HAE) Company Profile
HAE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
76.09 | 3.47B | 1.36B | 123.81M | 20.35M | 2.41 |
|
ABT
Abbott Laboratories
|
136.50 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.86 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
398.17 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.13 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.79 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-07 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 開始されました | JP Morgan | Overweight |
| 2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 開始されました | CL King | Buy |
| 2024-09-11 | 開始されました | BofA Securities | Neutral |
| 2024-09-10 | 開始されました | BTIG Research | Buy |
| 2024-06-12 | アップグレード | Needham | Hold → Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-01-27 | ダウングレード | Needham | Buy → Hold |
| 2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-08-17 | 再開されました | Raymond James | Outperform |
| 2021-06-17 | 開始されました | Citigroup | Buy |
| 2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 開始されました | Needham | Buy |
| 2019-08-07 | 繰り返されました | Barrington Research | Outperform |
| 2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 繰り返されました | Barrington Research | Outperform |
| 2018-08-09 | 繰り返されました | Barrington Research | Outperform |
| 2018-02-07 | 繰り返されました | Barrington Research | Outperform |
| 2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 繰り返されました | Barrington Research | Outperform |
| 2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
| 2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
| 2016-08-02 | 繰り返されました | Jefferies | Buy |
| 2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
Kalkine: Haemonetics (NYSE:HAE) Reflects Unique Sector Metrics in the russell 1000 - Kalkine Media
Haemonetics at Goldman Sachs Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Blood Platelets Market Deep Research Report with Forecast - openPR.com
Haemonetics at Goldman Sachs Conference: Strategic Growth and Challenges - Investing.com
Transcript : Haemonetics Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 08 - MarketScreener
Zacks Research Decreases Earnings Estimates for Haemonetics - Defense World
Q3 EPS Estimates for Haemonetics Decreased by Zacks Research - Defense World
Are Investors Undervaluing Haemonetics Corporation (NYSE:HAE) By 36%? - Yahoo Finance
Haemonetics to Present at Goldman Sachs 46th Annual Global Healthcare Conference - Quantisnow
Haemonetics (HAE) – Investment Analysts’ Recent Ratings Updates - Defense World
Decoding Haemonetics Corp (HAE): A Strategic SWOT Insight - GuruFocus
HAEMONETICS CORP SEC 10-K Report - TradingView
JMP maintains Haemonetics stock $100 target post-results By Investing.com - Investing.com Canada
What 4 Analyst Ratings Have To Say About Haemonetics - Benzinga
Haemonetics (HAE) Stock Rating and Price Target Reaffirmed by JMP Securities | HAE Stock News - GuruFocus
JMP maintains Haemonetics stock $100 target post-results - Investing.com
Haemonetics Co. (NYSE:HAE) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Haemonetics Corporation (NYSE:HAE) Q4 2025 Earnings Call Transcript - Insider Monkey
HAE Stock Gains on Q4 Earnings and Revenue Beat, Margins Up - Yahoo Finance
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Haemonetics Corporation Just Beat EPS By 8.7%: Here's What Analysts Think Will Happen Next - Yahoo Finance
Haemonetics Full Year 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Here's What Key Metrics Tell Us About Haemonetics (HAE) Q4 Earnings - Yahoo Finance
Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lo - GuruFocus
Raymond James Reiterates Strong Buy on Haemonetics (HAE) with Lowered Price Target | HAE Stock News - GuruFocus
Raymond James Adjusts Haemonetics (HAE) Price Target to $105, Ma - GuruFocus
Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - GuruFocus
Haemonetics Corp (HAE) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Haemonetics (HAE) Rating Maintained, Price Target Lowered to $84 | HAE Stock News - GuruFocus
Haemonetics: Fiscal Q4 Earnings Snapshot - MySA
Transcript : Haemonetics Corporation, Q4 2025 Earnings Call, May 08, 2025 - marketscreener.com
Earnings call transcript: Haemonetics Q4 2025 beats EPS forecast, stock rises - Investing.com
Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance
Haemonetics' Fiscal Q4 Adjusted Earnings Rise, Revenue Falls; Fiscal 2026 Outlook Issued - marketscreener.com
Haemonetics Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Haemonetics earnings beat by $0.02, revenue topped estimates - Investing.com
Haemonetics (NYSE:HAE) Surprises With Q1 Sales - Yahoo Finance
Haemonetics Corp Surpasses Q4 Expectations with EPS of $1.17 and Revenue of $331 Million - GuruFocus
Haemonetics (HAE) Surpasses Q4 Revenue Expectations | HAE Stock News - GuruFocus
Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow
Haemonetics Corporation announces an Equity Buyback for $500 million worth of its shares. - marketscreener.com
Earnings To Watch: Haemonetics Corp (HAE) Reports Q4 2025 Result - Yahoo Finance
Haemonetics (HAE) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
Haemonetics Sues Terumo Over Plasma Tech Patents - Law360
Haemonetics (NYSE:HAE) Upgraded to “Buy” at StockNews.com - Defense World
Haemonetics (HAE) Expected to Announce Quarterly Earnings on Thursday - Defense World
BofA Securities’s latest rating for HAE stock - knoxdaily.com
Envestnet Asset Management Inc. Buys 4,217 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Taking on analysts’ expectations and winning: Haemonetics Corp (HAE) - Sete News
How Do Investors Really Feel About Haemonetics?Haemonetics (NYSE:HAE) - Benzinga
Bank of Montreal Can Sells 12,518,398 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
1.35%
0.44%
大文字化:
|
ボリューム (24 時間):